EVERLIGHT RADIOLOGY acquired by LIVINGBRIDGE
Context
Livingbridge has announced the acquisition of a stake in Everlight Radiology, a world-renowned teleradiology provider, from Intermediate Capital Group (ICG), a global alternative asset manager. This secondary LBO transaction provides the technology-enabled healthcare platform with a new premier institutional sponsor to back its next international growth chapter.
EVERLIGHT RADIOLOGY, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a level close to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Everlight Radiology is a premier global technology-enabled teleradiology platform specializing in emergency (vrad) and routine diagnostic reporting services. Established in 2006 and operating out of hubs in the UK, Australia, New Zealand, and Ireland, the company serves as a mission-critical infrastructure partner for public hospital networks (such as the UK's NHS) and private healthcare operators. Its highly defensible business model centers on a proprietary global "follow-the-sun" operational framework. By leveraging a vast cloud-based network of accredited, consultant--level radiologists stationed across different time zones, Everlight delivers rapid, high-fidelity scan interpretations 24/7/365, effectively converting urgent night-time hospital requests into daytime working hours for remote specialists.
Ent. Value
AUD 500M–1.5bn
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (AUD)
Similar deals in Health Providers
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2021 | ARES / BPIFRANCE | POINT VISION | FRANCE | Ophthalmology |
| 10/2021 | IVC EVIDENSIA | VETONE | FRANCE | Vet Clinics |
| 08/2021 | COLOSSEUM DENTAL GROUP | CURAEOS | NETHERLANDS | Dental Centers |
| 07/2021 | OMERS | AMEDES | GERMANY | Labs (Biology) |
| 07/2021 | WREN HOUSE | ALMAVIVA SANTÉ | FRANCE | Clinics / Hospitals |
| 07/2021 | EQT PARTNERS | BLIKK GROUP | GERMANY | Radiology |
| 07/2021 | CERBA HEALTHCARE | LIFEBRAIN | ITALY | Labs (Biology) |
| 07/2021 | EQT PARTNERS | MEINE RADIOLOGIE | GERMANY | Radiology |
| 05/2021 | INFRATIL | PACIFIC RADIOLOGY GROUP | NEW ZEALAND | Radiology |
| 04/2021 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Nursing Homes |
REFERENCES
Valuation range: EV AUD 500M–1.5bn
EBITDA range: AUD 25–50M
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of EVERLIGHT RADIOLOGY by LIVINGBRIDGE are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: everlight radiology
Acquirer: livingbridge